Real-world insights on COVID-19 vaccine effectiveness and infection risk factors from CanPath’s SUPPORT-Canada study
As Canada continues to face waves of COVID-19 infections, with new variants emerging and immunity remaining elusive, the need for accurate data and insights has never been greater. Despite Canada having one of the highest vaccination rates in the world, the threat of future surges in cases remains a concern.
This is where CanPath's SUPPORT-Canada study comes in. Over the past three years, the study has collected rich data from 22,300 participants to measure vaccine effectiveness and evaluate the association between participant characteristics and infection risk. By surveying a large number of engaged participants across the country, we can determine specific interactions that together may be used to identify those most at risk across Canada.
Join us for a hybrid event led by Dr. Victoria Kirsh, Scientific Associate at the Ontario Health Study, on Tuesday, May 30th from 12 to 1 p.m. EDT, where she will delve into the insights gleaned from this groundbreaking study. Discover the latest findings on vaccine effectiveness against the Omicron variant, the importance of time since last vaccination, and the benefits and drawbacks of different vaccines and booster shots, including the latest findings on bivalent vs. monovalent boosters.
Join us via Zoom Webinar or in-person at the Dalla Lana School of Public Health. In-person tickets are limited.